Mitchell Silver
3 Papers
2 Citations
Mitchell Silver is an academic researcher. The author has contributed to research in topics: Medicine & Retrospective cohort study. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal
Christopher J. Kwolek,Michael R. Jaff,J. Ignacio Leal,L. Nelson Hopkins,Rasesh M. Shah,Todd M. Hanover,Sumaira Macdonald,Richard P. Cambria,Angel Flores,Ignacio Leal,Antonio Orgaz,Richard P. Cambria,Mark F. Conrad,Christopher J. Kwolek,Glenn M. LaMuraglia,Elad Levy,Adnan H. Siddiqui,Kenneth Snyder,Rasesh M. Shah,Christopher L. Stout,Mark P. Androes,Bruce H. Gray,Tod Hanover,Manny Mehta,Dawn M. Coleman,Enrique Criado,Katherine A. Gallagher,Vikram S. Kashyap,Russell A. Becker,Nitin Malhotra,Robert G. Molnar,Mahmoud B. Malas,Jim G. Melton,Brian G. DeRubertis,Wes Moore,William J. Quinones-Baldrich,Peter Morton,Jeffrey M. Apple,Mazin I. Foteh,Jeffrey Jim,Brian G. Rubin,Sam S. Ahn,Robert Feldtman,Kenneth Kollenmeyer,Daniel G. Clair,Sean P. Lyden,Edward Connolly,Philip M. Meyers,Nick Morrisey,Anthony Pucillo,Gary M. Ansel,Jefferson Lyons,Mitchell Silver,Michael Jaff,Daryl R. Gress,William A. Gray +55 more
TL;DR: The ROADSTER trial demonstrate that the use of the ENROUTE Transcarotid NPS is safe and effective at preventing stroke during CAS, and the overall stroke rate of 1.4% is the lowest reported to date for any prospective, multicenter clinical trial of CAS.
386
Refinement of anatomic indications for the Nellix System for endovascular aneurysm sealing based on 2-year outcomes from the EVAS FORWARD IDE trial.
Jeffrey P. Carpenter,John S. Lane,Jose Trani,Sajjad Hussain,Christopher Healey,Clifford J. Buckley,Homayoun Hashemi,Robert F. Cuff,Paul D. Hayes,Satish C. Muluk,Javier Vasquez,Clifford J. Buckley,Neal C. Hadro,Steven Lalka,Frank R. Arko,Ralph Ierardi,Daniel G. Clair,Lester Lee Kirksey,Cheong J. Lee,Nelson Bernado,James F. Benenati,Timothy M. Sullivan,Elliot Stephenson,Steve Tyndall,Mitchell Silver,Stephen P. Murray,Michel M.P.J. Reijnen,Stuart A. Harlin,Huey B. McDaniel,John S. Lane,Nikhil Kansal,Zvonimir Krajcer,Kevin J. Bruen,Luis R. Leon,Dittmar Böckler,Michel S. Makaroun,Jeffrey Indes,Timur P. Sarac +37 more
TL;DR: The 2‐year results of the investigational device exemption pivotal trial stratified according to the new and original criteria for selection of patients, which revealed a signal of migration, leading to a field safety notification issued by the manufacturer on October 21, 2016 and refinements to the instructions for use (IFU).
34
Proper technical procedures improved outcomes in a retrospective analysis of EVAS FORWARD IDE trial 3-year results.
Jeffrey P. Carpenter,John S. Lane,Jose Trani,Sajjad Hussain,Christopher Healey,Homayoun Hashemi,Robert F. Cuff,Paul D. Hayes,Satish C. Muluk,Javier Vasquez,Clifford J. Buckley,Frank R. Arko,Neal C. Hadro,Steven Lalka,Ralph Ierardi,Daniel G. Clair,Lester Lee Kirksey,Cheong J. Lee,Nelson Bernado,James F. Benenati,Timothy M. Sullivan,Elliot Stephenson,Steve Tyndall,Mitchell Silver,Stephen P. Murray,Michel M.P.J. Reijnen,Stuart A. Harlin,Huey B. McDaniel,John S. Lane,Nikhil Kansal,Zvonimir Krajcer,Kevin J. Bruen,Luis R. Leon,Dittmar Böckler,Michel S. Makaroun,Jeffrey Indes,Timur P. Sarac +36 more
TL;DR: This post hoc analysis suggests that achieving a 10-mm proximal and distal seal with adequate positioning of the endograft with respect to the renal arteries is associated with improved patient outcomes.
3